Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab
NCT01515189
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
831
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
BIOLOGICAL:
Ipilimumab
Sponsor
Bristol-Myers Squibb